| Literature DB >> 30408076 |
Léon Nshimyumukiza1,2, Jessica R L Lieffers3, John Paul Ekwaru1, Arto Ohinmaa1, Paul J Veugelers1.
Abstract
A high-quality diet is associated with a reduced of risk of chronic disease and all-cause mortality. In this study, we assessed changes in diet quality and the associated economic burden in the Canadian population between 2004 and 2015. We used a prevalence-based cost-of-illness approach. We first calculated the diet quality using the Healthy Eating Index-Canada-2010 (HEI-C-2010) and 24-hour recall data from the Canadian Community Health Surveys (CCHS) on nutrition (CCHS 2004 cycle 2.2 and the CCHS-NU 2015). We then retrieved relative risks of HEI-2010 quintiles for chronic diseases from meta-analyses. Based on the proportions of the population following diets of varying qualities and these relative risks, we computed the population-attributable fractions and attributable costs (direct health care and indirect costs) by survey year (2004 and 2015) as well as by age and sex group. Costs were estimated in 2017 Canadian dollars for comparison purposes. We observed that on average the diet quality of Canadians improved between 2004 and 2015: the proportion of the Canadian population that did not eat a diet of high quality decreased from 83% to 76%. This improvement in diet quality translated in a decrease in economic burden of $133 million, down from $13.21 billion in 2004 to $13.08 billion in 2015. The economic burden decreased by $219 million among males but increased by $86 million among females. It also decreased among people under the age of 65 years ($333 million) but increased among those over 65 years ($ 200 million). Our findings suggest that, despite some temporal improvements, the diet of the majority of Canadians is of poor quality resulting in a high attributable economic burden. Policy and decision makers are encouraged to expand nutrition programs and policies and to specifically target the elderly in order to prevent chronic diseases and reduce health care costs.Entities:
Mesh:
Year: 2018 PMID: 30408076 PMCID: PMC6224068 DOI: 10.1371/journal.pone.0206877
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Healthy Eating Index-Canada 2010 (HEI-C 2010).
| Component | Max pts | Standard for max score | Standard for min score (0) |
|---|---|---|---|
| Adequacy Sub-score | 60 | ||
| Total fruits and vegetables | 10 | 4–10 servings | No servings |
| Whole fruit | 5 | 0.84–2.1 servings | No servings |
| Greens and beans | 5 | 0.42–1.05 servings | No servings |
| Whole grains | 10 | 1.5–4 servings | No servings |
| Dairy | 10 | 2–4 servings | No servings |
| Total protein foods | 5 | 1–3 servings | No servings |
| Seafood and plant proteins | 5 | 0.32–0.96 servings | No servings |
| Fatty acids | 10 | (PUFA | (PUFA + MUFA)/SFA ≤ 1.2 |
| Moderation Sub-score | 40 | ||
| Refined grains | 10 | <50% of grains refined | ≥50% of grains refined |
| Sodium | 8 to 10 | AI | 2x UL |
| Empty calories | 20 | ≤ 19% of energy | ≥ 50% of energy |
| Total HEI-C 2010 Score | 100 | ||
Source: Jessri et al.2017 [16]
1PUFA: polyunsaturated fatty acids;
2MUFA: monounsaturated fatty acids;
3SFA: saturated fat;
4AI: Adequate intake;
5 UL: Tolerable upper intake level.
Percentages of the 2004 and 2015 Canadian population ≥ 2 years by age and sex and by HEI-C 2010 quintile.
| Female | Male | ||||||
|---|---|---|---|---|---|---|---|
| 2004 | 2015 | 2015 vs 2004 | 2004 | 2015 | 2015 vs 2004 | ||
| <15 years | Quintile 1 | 15.7 | 11.2 | -4.5 | 18.8 | 12.4 | -6.4 |
| Quintile 2 | 20.0 | 15.4 | -4.6 | 18.6 | 18.2 | -0.6 | |
| Quintile 3 | 20.5 | 20.8 | -0.3 | 20.3 | 18.4 | -1.9 | |
| Quintile 4 | 25.2 | 23.0 | -2.2 | 21.9 | 22.8 | -0.9 | |
| Quintile 5 | 18.6 | 29.7 | +11.1 | 20.3 | 28.1 | +7.8 | |
| 15–34 years | Quintile 1 | 21.8 | 18.8 | -3.0 | 34.9 | 29.9 | -4.0 |
| Quintile 2 | 24.0 | 18.4 | -5.6 | 26.8 | 19.5 | -7.3 | |
| Quintile 3 | 19.6 | 20.1 | +0.5 | 19.4 | 24.5 | +4.9 | |
| Quintile 4 | 19.8 | 19.2 | -0.6 | 13.5 | 14.6 | +0.9 | |
| Quintile 5 | 14.9 | 23.4 | +8.5 | 5.4 | 11.5 | +6.1 | |
| 35–54 years | Quintile 1 | 14.5 | 13.9 | -0.6 | 26.1 | 22.8 | -4.7 |
| Quintile 2 | 18.5 | 15.9 | -3.4 | 27.1 | 20.7 | -6.4 | |
| Quintile 3 | 20.9 | 17.4 | -3.5 | 20.5 | 21.7 | +1.2 | |
| Quintile 4 | 22.3 | 22.2 | -0.1 | 17.1 | 16.1 | -1.0 | |
| Quintile 5 | 23.7 | 30.6 | +6.9 | 9.2 | 18.6 | +9.4 | |
| 55–64 years | Quintile 1 | 12.5 | 14.8 | +2.3 | 19.7 | 18.0 | -1.7 |
| Quintile 2 | 15.4 | 12.2 | -3.2 | 24.0 | 18.6 | -5.4 | |
| Quintile 3 | 17.8 | 17.4 | -0.4 | 18.0 | 20.0 | +2.0 | |
| Quintile 4 | 21.7 | 25.2 | +3.5 | 20.7 | 19.8 | -0.9 | |
| Quintile 5 | 32.6 | 30.4 | -2.2 | 17.6 | 23.6 | +6.0 | |
| 65–74 years | Quintile 1 | 11.0 | 11.2 | -0.2 | 18.2 | 18.4 | +0.2 |
| Quintile 2 | 17.3 | 14.9 | -2.4 | 17.3 | 16.8 | -0.5 | |
| Quintile 3 | 19.4 | 16.6 | -2.6 | 19.8 | 28.6 | +8.8 | |
| Quintile 4 | 22.7 | 22.5 | -0.2 | 23.9 | 19.8 | -4.1 | |
| Quintile 5 | 29.6 | 34.8 | +5.2 | 20.8 | 16.4 | -4.4 | |
| 75+ years | Quintile 1 | 7.7 | 12.3 | +5.6 | 15.0 | 15.9 | +0.9 |
| Quintile 2 | 15.3 | 14.5 | -0.8 | 17.7 | 16.4 | -1.3 | |
| Quintile 3 | 20.4 | 20.6 | +0.2 | 20.7 | 20.9 | +0.2 | |
| Quintile 4 | 27.3 | 18.7 | -8.6 | 23.0 | 23.2 | +0.2 | |
| Quintile 5 | 29.3 | 33.9 | +4.6 | 16.5 | 23.7 | +7.2 | |
Population attributable fractions (PAFs) for unhealthy diet presented by age group, sex and chronic disease.
| Age group | Chronic disease (ICD-10 Code) | PAFs (%) | |||||
|---|---|---|---|---|---|---|---|
| Male | Female | ||||||
| 2004 | 2015 | 2015 vs 2004 | 2004 | 2015 | 2015 vs 2004 | ||
| < 15 years | Colorectal cancer(C20) | 36.7 | 32.1 | -4.6 | 35.6 | 30.6 | -5.0 |
| Esophagus cancer(C15) | 52.9 | 48.3 | -4.6 | 51.7 | 46.7 | -5.0 | |
| Stomach/gastric cancer(C16) | 19.1 | 16.5 | -2.6 | 18.5 | 15.7 | -2.8 | |
| Hepatocellular cancer(C22) | 44.3 | 39.8 | -4.4 | 43.1 | 38.3 | -4.8 | |
| Larynx cancer(C32) | 59.3 | 55.0 | -4.3 | 58.1 | 53.4 | -4.7 | |
| Oral cancer(C00-C14) | 59.3 | 55.0 | -4.3 | 58.1 | 53.4 | -4.7 | |
| Pancreas cancer(C25) | 23.9 | 20.7 | -3.2 | 23.1 | 19.6 | -3.5 | |
| Prostate cancer(C61) | 10.9 | 9.2 | -1.7 | - | - | - | |
| Lung cancer (C34) | 25.4 | 21.8 | -3.6 | 24.5 | 20.7 | -3.8 | |
| Type 2 diabetes (E10-E14) | 20.5 | 17.6 | -2.9 | 19.8 | 16.7 | -3.2 | |
| Ischemic stroke(I63) | 33.5 | 29.2 | -4.3 | 32.4 | 27.8 | -4.6 | |
| Heart Failure(I50) | 33.5 | 29.2 | -4.3 | 32.4 | 27.8 | -4.6 | |
| Ischemic Heart Disease (I20-I25) | 33.5 | 29.2 | -4.3 | 32.4 | 27.8 | -4.6 | |
| 15–34 years | Colorectal cancer(C20) | 46.8 | 43.3 | -3.5 | 40.1 | 36.6 | -3.5 |
| Esophagus cancer(C15) | 61.8 | 58.9 | -2.9 | 56.0 | 52.7 | -3.3 | |
| Stomach/gastric cancer(C16) | 25.1 | 23.0 | -2.2 | 21.1 | 19.0 | -2.1 | |
| Hepatocellular cancer(C22) | 53.2 | 50.2 | -3.0 | 47.3 | 44.0 | -3.3 | |
| Larynx cancer(C32) | 67.4 | 64.8 | -2.6 | 62.1 | 59.1 | -3.0 | |
| Oral cancer(C00-C14) | 67.4 | 64.8 | -2.6 | 62.1 | 59.1 | -3.0 | |
| Pancreas cancer(C25) | 31.4 | 28.7 | -2.7 | 26.3 | 23.7 | -2.6 | |
| Prostate cancer(C61) | 15.3 | 13.7 | -1.6 | - | - | - | |
| Lung cancer (C34) | 33.7 | 30.7 | -3.0 | 28.1 | 25.1 | -3.0 | |
| Type 2 diabetes (E10-E14) | 27.7 | 25.1 | -2.6 | 22.8 | 20.3 | -2.5 | |
| Stroke(I63) | 43.2 | 39.8 | -3.4 | 36.7 | 33.2 | -3.5 | |
| Heart Failure(I50) | 43.2 | 39.8 | -3.4 | 36.7 | 33.2 | -3.5 | |
| IHD(I20-I25) | 43.2 | 39.8 | -3.4 | 36.7 | 33.2 | -3.5 | |
| 35-54years | Colorectal cancer(C20) | 43.2 | 39.7 | -3.5 | 34.2 | 31.9 | -2.3 |
| Esophagus cancer(C15) | 58.7 | 55.7 | -3.0 | 50.3 | 48.3 | -2.0 | |
| Stomach/gastric cancer(C16) | 23.0 | 20.8 | -2.2 | 17.7 | 16.4 | -1.3 | |
| Hepatocellular cancer(C22) | 50.1 | 47.0 | -3.1 | 41.8 | 39.7 | -2.1 | |
| Larynx cancer(C32) | 64.6 | 61.8 | -2.7 | 56.8 | 55.0 | -1.8 | |
| Oral cancer(C00-C14) | 64.6 | 61.8 | -2.7 | 56.8 | 55.0 | -1.8 | |
| Pancreas cancer(C25) | 28.7 | 26.0 | -2.7 | 22.1 | 20.5 | -1.6 | |
| Prostate cancer(C61) | 13.7 | 12.1 | -1.6 | - | - | - | |
| Lung cancer (C34) | 30.7 | 27.7 | -3.0 | 23.4 | 21.6 | -1.8 | |
| Type 2 diabetes (E10-E14) | 25.1 | 22.5 | -2.6 | 18.9 | 17.4 | -1.5 | |
| Stroke(I63) | 39.7 | 36.3 | -3.4 | 31.1 | 28.9 | -2.2 | |
| Heart Failure(I50) | 39.7 | 36.3 | -3.4 | 31.1 | 28.9 | -2 | |
| Ischemic Heart Disease (I20-I25) | 39.7 | 36.3 | -3.4 | 31.1 | 28.9 | -2.2 | |
| 55–64 years | Colorectal cancer(C20) | 38.7 | 36.1 | -2.6 | 30.8 | 31.2 | +0.3 |
| Esophagus cancer(C15) | 54.7 | 52.3 | -2.4 | 47.1 | 47.6 | +0.5 | |
| Stomach/gastric cancer(C16) | 20.3 | 18.7 | -1.5 | 15.8 | 16.0 | +0.2 | |
| Hepatocellular cancer(C22) | 46.0 | 43.7 | -2.4 | 38.6 | 39.0 | +0.4 | |
| Larynx cancer(C32) | 60.9 | 58.7 | -2.2 | 53.8 | 54.4 | +0.6 | |
| Oral cancer(C00-C14) | 60.9 | 58.7 | -2.2 | 53.8 | 54.4 | +0.6 | |
| Pancreas cancer(C25) | 25.3 | 23.4 | -1.9 | 19.7 | 19.9 | +0.2 | |
| Prostate cancer(C61) | 11.7 | 10.7 | -1.0 | - | - | - | |
| Lung cancer (C34) | 27.0 | 24.8 | -2.2 | 20.8 | 21.0 | +0.2 | |
| Type 2 diabetes (E10-E14) | 21.9 | 20.1 | -1.8 | 16.8 | 16.9 | +0.1 | |
| Stroke(I63) | 35.3 | 32.9 | -2.4 | 27.9 | 28.2 | +0.3 | |
| Heart Failure(I50) | 35.3 | 32.9 | -2.4 | 27.9 | 28.2 | +0.3 | |
| Ischemic Heart Disease (I20-I25) | 35.3 | 32.9 | -2.4 | 27.9 | 28.2 | +0.3 | |
| 65–74 years | Colorectal cancer(C20) | 35.9 | 37.3 | +1.4 | 31.0 | 29.4 | -1.6 |
| Esophagus cancer(C15) | 52.2 | 53.3 | +1.1 | 47.1 | 45.6 | -1.5 | |
| Stomach/gastric cancer(C16) | 18.6 | 19.5 | +0.9 | 15.9 | 15.0 | -0.9 | |
| Hepatocellular cancer(C22) | 43.5 | 44.7 | +1.2 | 38.7 | 37.2 | -1.5 | |
| Larynx cancer(C32) | 58.6 | 59.6 | +1.0 | 53.8 | 52.4 | -1.4 | |
| Oral cancer(C00-C14) | 58.6 | 59.6 | +1.0 | 53.8 | 52.4 | -1.4 | |
| Pancreas cancer(C25) | 23.3 | 24.4 | +1.1 | 19.9 | 18.7 | -1.2 | |
| Prostate cancer(C61) | 10.6 | 11.2 | +0.6 | - | - | - | |
| Lung cancer (C34) | 24.7 | 25.9 | +1.2 | 21.0 | 19.7 | -1.3 | |
| Type 2 diabetes (E10-E14) | 20.0 | 21.0 | +1.0 | 16.9 | 15.8 | -1.1 | |
| Stroke(I63) | 32.7 | 34.0 | +1.3 | 28.1 | 26.6 | -1.6 | |
| Heart Failure(I50) | 32.7 | 34.0 | +1.3 | 28.1 | 26.6 | -1.5 | |
| Ischemic Heart Disease (I20-I25) | 32.7 | 34.0 | +1.3 | 28.1 | 26.6 | -1.5 | |
| 75+ years | Colorectal cancer(C20) | 34.6 | 34.3 | -0.3 | 28.2 | 30.7 | +2.5 |
| Esophagus cancer(C15) | 50.7 | 50.6 | -0.1 | 43.8 | 46.9 | +3.1 | |
| Stomach/gastric cancer(C16) | 17.9 | 17.7 | -0.2 | 14.4 | 15.7 | +1.3 | |
| Hepatocellular cancer(C22) | 42.1 | 41.9 | -0.2 | 35.7 | 38.5 | +2.8 | |
| Larynx cancer(C32) | 57.2 | 57.1 | -0.1 | 50.6 | 53.7 | +3.1 | |
| Oral cancer(C00-C14) | 57.2 | 57.1 | -0.1 | 50.6 | 53.7 | +3.1 | |
| Pancreas cancer(C25) | 22.4 | 22.2 | -0.2 | 18.0 | 19.6 | +1.6 | |
| Prostate cancer(C61) | 10.2 | 10.0 | -0.2 | - | - | - | |
| Lung cancer (C34) | 23.8 | 23.5 | -0.3 | 19.0 | 20.7 | +1.7 | |
| Type 2 diabetes (E10-E14) | 19.2 | 18.9 | -0.3 | 15.2 | 16.6 | +1.4 | |
| Stroke(I63) | 31.5 | 31.2 | -0.3 | 25.5 | 27.8 | +2.3 | |
| Heart Failure(I50) | 31.5 | 31.2 | -0.3 | 25.5 | 27.8 | +2.3 | |
| Ischemic Heart Disease (I20-I25) | 31.5 | 31.2 | -0.3 | 25.5 | 27.8 | +2.3 | |
*ICD-10, International Classification of Diseases, 10th Revision
Economic burden of unhealthy diet by chronic disease, gender and age group (in 2017 $ CAN) in Canada.
| Attributable costs in 2017 $ CAN | Changes 2015 vs 2004 | ||||||
|---|---|---|---|---|---|---|---|
| 2004 | 2015 | ||||||
| Direct | Indirect | Total | Direct | Indirect | Total | ||
| Colorectal cancer(C20) | 109 029 668 | 538 606 562 | 647 636 230 | 107 214 127 | 529 637 786 | 636 851 914 | -10 784 316 |
| Esophagus cancer(C15) | 46 535 728 | 229 886 495 | 276 422 223 | 46 066 272 | 227 567 383 | 273 633 657 | -2 788 566 |
| stomach/gastric cancer(C16) | 29 279 371 | 144 640 095 | 173 919 467 | 28 986 576 | 143 193 684 | 172 180 259 | -1 739 208 |
| Hepatocellular cancer(C22) | 13 984 178 | 69 081 841 | 83 066 020 | 13 690 859 | 67 632 841 | 81 323 699 | -1 742 321 |
| Larynx cancer(C32) | 34 245 916 | 169 174 824 | 203 420 740 | 33 972 017 | 167 821 764 | 201 793 781 | -1 626 959 |
| Oral cancer(C00-C14) | 130 646 735 | 645 394 871 | 776 041 605 | 133 179 854 | 657 908 477 | 791 088 329 | 15 046 724 |
| Pancreas cancer(C25) | 73 198 999 | 361 603 055 | 434 802 054 | 72 929 263 | 360 270 561 | 433 199 823 | -1 602 231 |
| Prostate cancer(C61) | 58 109 777 | 287 062 299 | 345 172 076 | 57 213 470 | 282 634 542 | 339 848 013 | -5 324 063 |
| Lung cancer (C34) | 139 890 329 | 691 058 228 | 830 948 557 | 138 337 103 | 683 385 288 | 821 722 390 | -9 226 167 |
| Type 2 diabetes (E10-E14) | 736 615 873 | 891 305 206 | 1 627 921 078 | 700 673 101 | 847 814 453 | 1 548 487 553 | -79 433 525 |
| Stroke(I63) | 418 337 971 | 719 541 310 | 1 137 879 280 | 426 446 233 | 733 487 522 | 1 159 933 756 | 22 054 476 |
| Heart Failure(I50) | 466 812 796 | 802 918 010 | 1 269 730 807 | 474 620 236 | 816 346 806 | 1 290 967 042 | 21 236 235 |
| Ischemic Heart Disease (I20-I25) | 1 989 777 241 | 3 422 416 855 | 5 412 194 096 | 1 961 447 510 | 3 373 689 716 | 5 335 137 226 | -77 056 870 |
| <15 years | 15 660 895 | 28 136 790 | 43 797 685 | 13 472 001 | 24 535 613 | 38 007 614 | -5 790 071 |
| 15–34 years | 63 552 723 | 103 521 887 | 167 074 610 | 57 540 350 | 94 324 290 | 151 864 640 | -15 209 970 |
| 35–54 years | 736 993 367 | 1 398 889 539 | 2 135 882 906 | 674 024 835 | 1 284 894 880 | 1 958 919 714 | -176 963 192 |
| 55–64 years | 923 070 850 | 1 945 257 212 | 2 868 328 061 | 878 618 081 | 1 854 232 431 | 2 732 850 513 | -135 477 549 |
| 65–74 years | 1 080 673 531 | 2 340 889 315 | 3 421 562 847 | 1 090 851 811 | 2 366 372 315 | 3 457 224 126 | 35 661 280 |
| 75+ years | 1 426 513 218 | 3 155 994 905 | 4 582 508 123 | 1 480 269 544 | 3 267 031 295 | 4 747 300 839 | 164 792 716 |
| Male | 2 687 141 216 | 5 719 965 722 | 8 407 106 937 | 2 609 869 447 | 5 578 584 181 | 8 188 453 627 | -218 653 311 |
| Female | 1 559 323 367 | 3 252 723 929 | 4 812 047 295 | 1 584 907 17 | 3 312 806 643 | 4 897 713 815 | 85 666 521 |
| 4 246 464 583 | 8 972 689 651 | 13 219 154 232 | 4 194 776 620 | 8 891 390 823 | 13 086 167 443 | -132 986 787 | |